Element Biosciences, Inc.

About Element Biosciences, Inc.

Element Biosciences aims to empower the scientific community by providing high-quality, affordable sequencing solutions to accelerate collective impact on humanity. Their mission focuses on opening new possibilities in biology through innovative technologies and platforms.

Products & Services

AVITI Family:A range of sequencing instruments including AVITI, AVITI24, and AVITI LT, designed for high-quality, affordable sequencing and multiomics.

AVITI24:A 5D multiomics system offering spatial, single-cell co-detection of RNA, protein, and morphology with rapid run times.

Reagents & Kits:Includes Cloudbreak, Trinity, Teton CytoProfiling, Elevate, and Adept kits for sequencing and library preparation.

Software:ElemBio Cloud and ElemBio Catalyst for data management and analysis in sequencing workflows.

Lab Services:Services like LoopSeq and Technology Access Program to support sequencing and research needs.

VITARI

AVITI24

AVITI

Avidite Base Chemistry (ABC)

Cloudbreak

Trinity

Specialties

DNA Sequencing RNA Sequencing Long-Read Sequencing 5D Multiomics Spatial Biology Single-Cell Analysis Avidite Base Chemistry (ABC) Agricultural Biotechnology Pharmaceutical Innovation Multiomics Spatial sequencing Single cell multiomics Direct In Sample Sequencing (DISS) High-throughput sequencing DNA/RNA sequencing

Funding History

Debug: View Raw Funding Data

#	Type	Amount Fields	Date Fields	Investors
1	RT: Series E T: - FT: Series E	A: 175000000 MR: - FA: $175 million FAN: 175000000	D: 2026-06-16 FD: 2026-06-16	1 investors
2	RT: Series E T: - FT: Series E	A: 175000000 MR: - FA: $175 million FAN: 175000000	D: 2026-06-09 FD: 2026-06-09	1 investors
3	RT: Series D T: - FT: Series D	A: 277000000 MR: - FA: over $277 million FAN: 277000000	D: 2024-07-11 FD: 2024-07-11	6 investors

Series E Latest

2026-06-16

$175.0M

1 investor (Pro only)

Series E 2026-06-09

$175.0M

Series D 2024-07-11

$277.0M

View 2 more funding rounds with Pro

Unlock Full Funding History

Growth Metrics

+45%

Employee Growth

YoY

3.2x

Funding Growth

Last Round

12

Markets

Operating

10K+

Customers

Active

View 3 more growth metrics with Pro

Unlock All Metrics

Mock Up

Team & Leadership

M

Molly He

CEO, Co-Founder, and Board Member

M

Michael Previte

CTO and SVP of Advanced Research, Co-Founder

M

Matthew Kellinger

VP of Biochemistry and Co-Founder

B

Brian Stolz

Chief People Officer

D

David Melaugh

General Counsel

F

Francisco Garcia

SVP of Informatics

View 17 more team members with Pro

Unlock Full Team Directory

Recent News